At its annual press conference on 22 March, specialty chemicals company Lanxess reported record sales and earnings figures during the 2011 financial year. Highlights the company touched upon were a 23 per cent rise in sales to 8,775 million euros, EBITDA pre exceptionals up 25 per cent to 1,146 million euros – the first time the one billion euro mark has been exceeded. The company’s EBITDA margin pre exceptionals came in at 13.1 per cent, compared with 12.9 percent the year before. Net income rose disproportionately compared with sales and EBITDA pre exceptionals, improving by one third from the previous year to 506 million euros. These positive results were achieved, the company stated, thanks to its price-before-volume strategy, successful acquisitions and focus on the emerging markets.